{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:42:33Z","timestamp":1771670553792,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s12265-023-10402-9","type":"journal-article","created":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T09:57:09Z","timestamp":1687514229000},"page":"1177-1183","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Fibrinogen-to-Albumin Ratio Is Associated with Poor Prognosis in Patients with Coronary Artery Disease: Findings from a Large Cohort"],"prefix":"10.1007","volume":"16","author":[{"given":"Xian-Geng","family":"Hou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Ting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Ying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Tong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0632-4626","authenticated-orcid":false,"given":"Xiang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,22]]},"reference":[{"key":"10402_CR1","unstructured":"Zhao D, Liu J, Wu Z. Overview of the history and important research of cardiovascular epidemiology in China[J]. Chin J Cardiovasc Dis. 2021;49(12):1081\u20137."},{"key":"10402_CR2","first-page":"542","volume":"29","author":"W Armstrong Paul","year":"2022","unstructured":"Armstrong Paul W, Bates Eric R, Gaudino M. Left main coronary disease: evolving management concepts. [J] Eur Heart J. 2022;29:542.","journal-title":"[J] Eur Heart J"},{"key":"10402_CR3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41569-021-00638-w","volume":"19","author":"K Derek","year":"2022","unstructured":"Derek K, Pradeep N. Clinical utility of polygenic risk scores for coronary artery disease. [J] Nat Rev Cardiol. 2022;19:291\u2013301.","journal-title":"[J] Nat Rev Cardiol"},{"key":"10402_CR4","first-page":"61","volume":"145","author":"G Deftereos Spyridon","year":"2022","unstructured":"Deftereos Spyridon G, BeerkensFrans J, Binita S, et al. Colchicine in coronary artery disease: in-depth review. [J] Circulation. 2022;145:61\u201378.","journal-title":"[J] Circulation"},{"key":"10402_CR5","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1093\/eurheartj\/ehx581","volume":"39","author":"M Hoogeveen Renate","year":"2018","unstructured":"Hoogeveen Renate M, Matthias N, Riksen Niels P, et al. Monocyte and haematopoietic progenitor reprogramming as common mechanism underlying chronic inflammatory and coronary artery diseases. [J] Eur Heart J. 2018;39:3521\u20137.","journal-title":"[J] Eur Heart J"},{"key":"10402_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11883-017-0661-2","volume":"19","author":"L Ben","year":"2017","unstructured":"Ben L, Herrington William G, David P, et al. The role of emerging risk factors in cardiovascular outcomes. [J] Curr Atheroscler Rep. 2017;19:28.","journal-title":"[J] Curr Atheroscler Rep"},{"key":"10402_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.gheart.2014.11.004","volume":"10","author":"M GijsbertsCrystel","year":"2015","unstructured":"GijsbertsCrystel M, den Ruijter HM, AsselbergsFolkert W, et al. Biomarkers of coronary artery disease differ between Asians and Caucasians in the general population. [J] Glob Heart. 2015;10:301-311.e11.","journal-title":"[J] Glob Heart"},{"key":"10402_CR8","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.autrev.2018.01.021","volume":"17","author":"O Esc\u00e1rcega Ricardo","year":"2018","unstructured":"Esc\u00e1rcega Ricardo O, Lipinski Michael J, Mario G-C, et al. Inflammation and atherosclerosis: cardiovascular evaluation in patients with autoimmune diseases. [J] Autoimmun Rev. 2018;17:703\u20138.","journal-title":"[J] Autoimmun Rev"},{"key":"10402_CR9","doi-asserted-by":"crossref","unstructured":"Larsen JB, Hvas AM. Fibrin clot properties in coronary artery disease: new determinants and prognostic markers.[J] Pol Arch Intern Med. 2021;131:16113.","DOI":"10.20452\/pamw.16113"},{"key":"10402_CR10","doi-asserted-by":"publisher","first-page":"e13550","DOI":"10.7717\/peerj.13550","volume":"10","author":"Z Yuyu","year":"2022","unstructured":"Yuyu Z, Shuman T, Danfeng Z, et al. Association between fibrinogen\/albumin ratio and severity of coronary artery calcification in patients with chronic kidney disease: a retrospective study. [J] PeerJ. 2022;10:e13550.","journal-title":"[J] PeerJ"},{"key":"10402_CR11","first-page":"4925498","volume":"2018","author":"Xu Qiaodong","year":"2018","unstructured":"Qiaodong Xu, Yongcong Y, Songgang G, et al. A novel inflammation-based prognostic score: the fibrinogen\/albumin ratio predicts prognoses of patients after curative resection for hepatocellular carcinoma. [J] J Immunol Res. 2018;2018:4925498.","journal-title":"[J] J Immunol Res"},{"key":"10402_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cca.2018.04.012","volume":"482","author":"C Shuaishuai","year":"2018","unstructured":"Shuaishuai C, Haixi Y, Juping D, et al. Prognostic significance of pre-resection albumin\/fibrinogen ratio in patients with non-small cell lung cancer: a propensity score matching analysis. [J] Clin Chim Acta. 2018;482:203\u20138.","journal-title":"[J] Clin Chim Acta"},{"key":"10402_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2021.04.012","volume":"328","author":"YY Zheng","year":"2021","unstructured":"Zheng YY, Wu TT, Guo QQ, Chen Y, Ma X, Ma YT, Zhang JY, Xie X. Long-term dual antiplatelet-induced intestinal injury resulting in translocation of intestinal bacteria into blood circulation increased the incidence of adverse events after PCI in patients with coronary artery disease. Atherosclerosis. 2021;328:1\u201310.","journal-title":"Atherosclerosis"},{"key":"10402_CR14","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.ajem.2016.03.003","volume":"34","author":"K O\u011fuz","year":"2016","unstructured":"O\u011fuz K, Halit A, Faruk E, et al. The relationship between fibrinogen to albumin ratio and severity of coronary artery disease in patients with STEMI. J Am J Emerg Med. 2016;34:1037\u201342.","journal-title":"J Am J Emerg Med"},{"key":"10402_CR15","doi-asserted-by":"crossref","unstructured":"Libby P, Tabas I, Fredman G, et al. Inflammation and its resolution as determinants of acute coronary syndromes.[J] Circ Res. 2014;114(12):1867\u201379.","DOI":"10.1161\/CIRCRESAHA.114.302699"},{"key":"10402_CR16","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1161\/ATVBAHA.115.306284","volume":"35","author":"A Duke","year":"2015","unstructured":"Duke A, Schreiner Pamela J, MacLehose Richard F, et al. Association of plasma \u03b3\u2019 fibrinogen with incident coronary artery disease: the Atherosclerosis Risk in Communities (ARIC) study. J Arterioscler Thromb Vasc Biol. 2015;35:2700\u20136.","journal-title":"J Arterioscler Thromb Vasc Biol"},{"key":"10402_CR17","doi-asserted-by":"crossref","unstructured":"Poznyak AV, Litvinova L, Poggio P, et al. From diabetes to atherosclerosis: potential of metformin for management of coronary artery disease. Int J Mol Sci. 2022;23(2):758.","DOI":"10.3390\/ijms23179738"},{"key":"10402_CR18","doi-asserted-by":"crossref","unstructured":"Kryczka KE, Kruk M, Demkow M, et al. Fibrinogen and a triad of thrombosis, inflammation, and the renin-angiotensin system in premature coronary artery disease in women: a new insight into sex-related differences in the pathogenesis of the disease.[J] Biomolecules. 2021;11(7):1036.","DOI":"10.3390\/biom11071036"},{"key":"10402_CR19","doi-asserted-by":"crossref","unstructured":"Wang J, Jia L, Li X, et al. New insights into the association between fibrinogen and coronary atherosclerotic plaque vulnerability: an intravascular optical coherence tomography study.[J].Cardiovasc Ther. 2019;8563717.","DOI":"10.1155\/2019\/8563717"},{"issue":"1","key":"10402_CR20","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12933-021-01409-0","volume":"20","author":"S Sharif","year":"2021","unstructured":"Sharif S, Van der Graaf Y, Cramer MJ, et al. Low-grade infammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes. [J] Cardiovasc Diabetol. 2021;20(1):220.","journal-title":"[J] Cardiovasc Diabetol."},{"key":"10402_CR21","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1177\/1076029616629210","volume":"23","author":"T M Mustafa","year":"2017","unstructured":"Mustafa T M, Fethullah G, Murat S, et al. Relation of plasma fibrinogen level with the presence, severity, and complexity of coronary artery disease. [J] Clin Appl Thromb Hemost. 2017;23:638\u201344.","journal-title":"[J] Clin Appl Thromb Hemost"},{"key":"10402_CR22","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.cca.2017.04.007","volume":"469","author":"K Deepak","year":"2017","unstructured":"Deepak K, Dibyajyoti B. Methods of albumin estimation in clinical biochemistry: past, present, and future. [J] Clin Chim Acta. 2017;469:150\u201360.","journal-title":"[J] Clin Chim Acta"},{"key":"10402_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ancard.2018.02.002","volume":"67","author":"S Arques","year":"2018","unstructured":"Arques S. Serum albumin and coronary artery diseases: a comprehensive review of the literature. [J] Ann Cardiol Angeiol (Paris). 2018;67:82\u201390.","journal-title":"[J] Ann Cardiol Angeiol (Paris)"},{"key":"10402_CR24","doi-asserted-by":"crossref","unstructured":"Zhu L, Chen M, Lin X. Serum albumin level for prediction of all-cause mortality in acute coronary syndrome patients: a meta-analysis.[J] Biosci Rep. 2020;40(1):BSR20190881.","DOI":"10.1042\/BSR20190881"},{"key":"10402_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2017.04.003","volume":"241","author":"C Shih-Chieh","year":"2017","unstructured":"Shih-Chieh C, Chun-Yen C, Hsin-Bang L, et al. Association of low serum albumin concentration and adverse cardiovascular events in stable coronary artery disease. J Int J Cardiol. 2017;241:1\u20135.","journal-title":"J Int J Cardiol"},{"key":"10402_CR26","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1158\/1078-0432.CCR-16-1647","volume":"23","author":"B-H Anna","year":"2017","unstructured":"Anna B-H, Stefanie A, Katharina A, et al. Integrative systemic and local metabolomics with impact on survival in high-grade serous ovarian cancer. J Clin Cancer Res. 2017;23:2081\u201392.","journal-title":"J Clin Cancer Res"},{"key":"10402_CR27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1159\/000446478","volume":"25","author":"E Hande","year":"2016","unstructured":"Hande E, Tuba \u00c7, Sedat \u00d6, et al. Plasma glycated albumin levels clearly detect hearing loss and atherosclerosis in patients with impaired fasting glucose. J Med Princ Pract. 2016;25:309\u201315.","journal-title":"J Med Princ Pract"},{"key":"10402_CR28","doi-asserted-by":"crossref","first-page":"107602961983538","DOI":"10.1177\/1076029619835383","volume":"25","author":"K Osman","year":"2019","unstructured":"Osman K, Cem O, Adnan K. Relationship between the reciprocal change in inflammation-related biomarkers (fibrinogen-to-albumin and hsCRP-to-albumin ratios) and the presence and severity of coronary slow flow. J Clin Appl Thromb Hemost. 2019;25:1076029619835383.","journal-title":"J Clin Appl Thromb Hemost"},{"key":"10402_CR29","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.3389\/fimmu.2018.01731","volume":"9","author":"G Kerstin","year":"2018","unstructured":"Kerstin G, Susann E, Heinz W, et al. The coagulation factors fibrinogen, thrombin, and factor XII in inflammatory disorders-a systematic review. J Front Immunol. 2018;9:1731.","journal-title":"J Front Immunol"},{"key":"10402_CR30","doi-asserted-by":"crossref","unstructured":"He D, Jiao Y, Yu T, et al. Prognostic value of fibrinogentoalbumin ratio in predicting 1 year clinical progression in patients with nonST elevation acute coronary syndrome undergoing percutaneous coronary intervention[J]. Exp Ther Med. 2019;18(4):2972\u20138.","DOI":"10.3892\/etm.2019.7890"},{"key":"10402_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cca.2019.02.018","volume":"493","author":"L Xiao","year":"2019","unstructured":"Xiao L, Jia Y, Wang X, et al. The impact of preoperative fibrinogen-albumin ratio on mortality in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J]. Clin Chim Acta. 2019;493:8\u201313.","journal-title":"Clin Chim Acta"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-023-10402-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-023-10402-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-023-10402-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T16:20:28Z","timestamp":1698682828000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-023-10402-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,22]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10402"],"URL":"https:\/\/doi.org\/10.1007\/s12265-023-10402-9","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,22]]},"assertion":[{"value":"23 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}